-
Je něco špatně v tomto záznamu ?
Bioprostheses and Mechanical Prostheses for Aortic Valve Replacement in Patients Aged 50 to 65 Years Offer Similar Long-Term Survival Rates
T. Toporcer, Š. Lukačín, A. Kraus, M. Homola, A. Bereš, M. Trebišovský, D. Radótzy, V. Rohn, A. Kolesár
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2014
PubMed Central
od 2015
Europe PubMed Central
od 2015
ProQuest Central
od 2021-01-01
Open Access Digital Library
od 2014-01-01
Health & Medicine (ProQuest)
od 2021-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2014
PubMed
39997478
DOI
10.3390/jcdd12020044
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Aortic valve replacement (AVR) is the definitive therapy for patients with severe aortic valve stenosis (AoS). The aim of this work is to compare the effect of a mechanical prosthesis (MP) and a bioprosthesis (BP) on the survival of patients aged 50-65 years after AVR. METHODS: The retrospective analysis included 276 patients aged 50 to 65 years who had undergone isolated AVR for AoS; 161 patients were implanted with an MP and 115 with a BP. Patient survival, adjusted for age, gender and risk parameters affecting survival, was assessed. A subgroup analysis was performed on the 208 patients with a modern valve (prosthesis models that are no longer used in clinical practice were removed from the sample). RESULTS: After adjusting for risk factors for overall survival as well as for age and sex, the implantation of an MP did not have a significant effect on overall survival in comparison to a BP, at a median follow-up of 10.3 years (p = 0.477). The size of the MP had no significant effect on overall survival either (HR: 1.29; 95%CI: 0.16-10.21; p = 0.812). However, the indexed effective orifice area of the BP had a positive effect on overall survival (HR: 0.09; 95%CI: 0.01-0.78; p = 0.029). CONCLUSIONS: The estimated survival of patients aged between 50 and 65 years after implantation of a BP with a sufficiently large indexed effective orifice area may exceed that of patients with an MP.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25008562
- 003
- CZ-PrNML
- 005
- 20250422095713.0
- 007
- ta
- 008
- 250408s2025 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/jcdd12020044 $2 doi
- 035 __
- $a (PubMed)39997478
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Toporcer, Tomáš $u Department of Heart Surgery, East Slovak Institute for Cardiovascular Diseases and Medical Faculty of Pavol Jozef Šafárik University, 04001 Košice, Slovakia $1 https://orcid.org/0000000341955180 $7 xx0106536
- 245 10
- $a Bioprostheses and Mechanical Prostheses for Aortic Valve Replacement in Patients Aged 50 to 65 Years Offer Similar Long-Term Survival Rates / $c T. Toporcer, Š. Lukačín, A. Kraus, M. Homola, A. Bereš, M. Trebišovský, D. Radótzy, V. Rohn, A. Kolesár
- 520 9_
- $a BACKGROUND: Aortic valve replacement (AVR) is the definitive therapy for patients with severe aortic valve stenosis (AoS). The aim of this work is to compare the effect of a mechanical prosthesis (MP) and a bioprosthesis (BP) on the survival of patients aged 50-65 years after AVR. METHODS: The retrospective analysis included 276 patients aged 50 to 65 years who had undergone isolated AVR for AoS; 161 patients were implanted with an MP and 115 with a BP. Patient survival, adjusted for age, gender and risk parameters affecting survival, was assessed. A subgroup analysis was performed on the 208 patients with a modern valve (prosthesis models that are no longer used in clinical practice were removed from the sample). RESULTS: After adjusting for risk factors for overall survival as well as for age and sex, the implantation of an MP did not have a significant effect on overall survival in comparison to a BP, at a median follow-up of 10.3 years (p = 0.477). The size of the MP had no significant effect on overall survival either (HR: 1.29; 95%CI: 0.16-10.21; p = 0.812). However, the indexed effective orifice area of the BP had a positive effect on overall survival (HR: 0.09; 95%CI: 0.01-0.78; p = 0.029). CONCLUSIONS: The estimated survival of patients aged between 50 and 65 years after implantation of a BP with a sufficiently large indexed effective orifice area may exceed that of patients with an MP.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Lukačín, Štefan $u Department of Heart Surgery, East Slovak Institute for Cardiovascular Diseases and Medical Faculty of Pavol Jozef Šafárik University, 04001 Košice, Slovakia $1 https://orcid.org/0000000159225958
- 700 1_
- $a Kraus, Andrea $u Institute of Mathematics and Statistics, Faculty of Science, Masaryk University, 602 00 Brno, Czech Republic
- 700 1_
- $a Homola, Marián $u Department of Heart Surgery, East Slovak Institute for Cardiovascular Diseases and Medical Faculty of Pavol Jozef Šafárik University, 04001 Košice, Slovakia $1 https://orcid.org/0009000880215453
- 700 1_
- $a Bereš, Anton $u Department of Heart Surgery, East Slovak Institute for Cardiovascular Diseases and Medical Faculty of Pavol Jozef Šafárik University, 04001 Košice, Slovakia
- 700 1_
- $a Trebišovský, Michal $u Department of Heart Surgery, East Slovak Institute for Cardiovascular Diseases and Medical Faculty of Pavol Jozef Šafárik University, 04001 Košice, Slovakia $1 https://orcid.org/0009000296075949
- 700 1_
- $a Radótzy, Denis $u Department of Heart Surgery, East Slovak Institute for Cardiovascular Diseases and Medical Faculty of Pavol Jozef Šafárik University, 04001 Košice, Slovakia
- 700 1_
- $a Rohn, Vilém $u II. Surgery Department-Cardiovascular Surgery, General University Hospital and First Faculty of Medicine, Charles University, 128 08 Prague, Czech Republic
- 700 1_
- $a Kolesár, Adrián $u Department of Heart Surgery, East Slovak Institute for Cardiovascular Diseases and Medical Faculty of Pavol Jozef Šafárik University, 04001 Košice, Slovakia $1 https://orcid.org/0000000293907191
- 773 0_
- $w MED00194905 $t Journal of cardiovascular development and disease $x 2308-3425 $g Roč. 12, č. 2 (2025)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39997478 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250408 $b ABA008
- 991 __
- $a 20250422095714 $b ABA008
- 999 __
- $a ok $b bmc $g 2306420 $s 1245637
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2025 $b 12 $c 2 $e 20250126 $i 2308-3425 $m Journal of cardiovascular development and disease $n J Cardiovasc Dev Dis $x MED00194905
- LZP __
- $a Pubmed-20250408